About

Company description

Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. 

  • We put all of our energy and experience into being your partner of choice 
  •  We create value for customers through manufacturing excellence, reliable quality and innovative science 
  •  Our people are the experts that our customers enjoy working with We truly offer our customers an end-to-end partnership for the research, development and manufacture of small molecule therapeutics at every stage of the drug lifecycle.

Quick facts

Affiliated categories: API Contract Manufacturing |Bio Services |Contract Manufacturing More

Upcoming events

18 jun 2019

CPhI & PMEC China 2019

18 - 20 June 2019 SNIEC, Shanghai, China Visit us at stand E1A58 Book a meeting See our Exhibitor Profile   See full Exhibitor List
5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 41C10 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 1006 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 5G12 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 613 See our Exhibitor Profile   See full Exhibitor List

News about Cambrex

Cambrex completes expansion and manufacturing capability upgrades in Milan

18 Mar 2019

Cambrex completes expansion and manufacturing capability upgrades in Milan

New laboratory has installed a flow chemistry system to allow for continuous manufacturing development.

Read more

2 Jan 2019

Cambrex completes acquisition of Avista Pharma Solutions

Acquisition adds a full complement of early-stage development capabilities to Cambrex’s larger scale capabilities for APIs and finished dosage forms.

Read more

12 Dec 2018

Cambrex expands analytical capabilities

The $1 million investment will assist in getting new products to commercial launch faster.

Read more

20 Nov 2018

Acquisition boosts Cambrex's early-stage development capabilities

Acquisition adds early-stage API and finished dosage form development & testing services to its global contract development & manufacturing network.

Read more